Insider · CIK 0001279735

BOCK LOUIS C

Reports to the SEC for 9 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001279735

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2021-05-27	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2020-05-29	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2019-05-22	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2018-05-23	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,375 sh	—	—	0
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	0
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,625 sh	—	—	0
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+218 sh	$28.00	+$6,104	218
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+218 sh	$20.00	+$4,360	436
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+218 sh	$32.00	+$6,976	654
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,562 sh	$30.96	+$48.4K	2,216
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$15.04	+$94K	8,466
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,375 sh	$14.88	+$65.1K	12,841
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,625 sh	$12.00	+$67.5K	18,466
2018-03-12	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$15.52	+$97K	24,716
2018-03-12	ZOGENIX, INC.S Sale	Director	SSale	−24.7K sh	$44.83	−$1.11M	0
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−218 sh	—	—	0
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−218 sh	—	—	0
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−218 sh	—	—	0
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,562 sh	—	—	0
2018-03-12	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	0
2017-07-14	Orexigen Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2017-05-23	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-07-13	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-07-12	Orexigen Therapeutics, Inc.Stock OptionA Award	Director	AAward	+15K sh	—	—	15,000
2016-01-11	Scorpius Holdings, Inc.Stock OptionsA Award	Director	AAward	+23.8K sh	—	—	23,810
2015-06-18	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+72K sh	—	—	72,000
2015-06-09	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2014-11-18	Orexigen Therapeutics, Inc.P Purchase	Director	PPurchase	+700 sh	$5.58	+$3,905.3	700
2014-11-18	Orexigen Therapeutics, Inc.P Purchase	Director	PPurchase	+625 sh	$5.58	+$3,486.875	27,677
2014-11-12	Orexigen Therapeutics, Inc.P Purchase	Director	PPurchase	+27.1K sh	$5.57	+$151K	27,052
2013-06-18	ZOGENIX, INC.Right to buy stockA Award	Director	AAward	+45K sh	—	—	155,250
2013-06-05	Orexigen Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2012-06-07	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2012-06-06	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2012-04-27	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2011-09-21	ZOGENIX, INC.P Purchase	Director	PPurchase	+1.25M sh	$2.00	+$2.5M	5,321,546
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Common StockC Conversion	Director	CConversion	+29.3K sh	—	—	29,254
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Common StockC Conversion	Director	CConversion	+14.6K sh	—	—	14,627
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Common StockC Conversion	Director	CConversion	+18.3K sh	—	—	18,285
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Series A Preferred StockC Conversion	Director	CConversion	−69.5K sh	—	—	0
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	Director	CConversion	+1.37M sh	—	—	1,370,070
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	Director	CConversion	+172K sh	—	—	1,541,696
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	Director	CConversion	+347K sh	$9.00	+$3.12M	1,888,519
2011-08-02	Horizon Therapeutics Public Ltd CoP Purchase	Director	PPurchase	+316K sh	$9.00	+$2.84M	2,204,465
2011-08-02	Horizon Therapeutics Public Ltd CoSeries A Convertible Preferred StockC Conversion	Director	CConversion	−3.25M sh	—	—	0

Recent filings

Accepted (ET)
Mar 94
BOCK LOUIS C0000899243-22-010304
SEC(opens sec.gov)
May 284
BOCK LOUIS C0001375151-21-000061
SEC(opens sec.gov)
Jun 294
BOCK LOUIS C0001375151-20-000108
SEC(opens sec.gov)
May 284
BOCK LOUIS C0001375151-19-000077
SEC(opens sec.gov)
May 244
BOCK LOUIS C0001375151-18-000042
SEC(opens sec.gov)
Mar 144
BOCK LOUIS C0001375151-18-000011
SEC(opens sec.gov)

Companies

Address

FOSTER CITY, CA, 94404